Related Experiment Video
Updated: Aug 19, 2026

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Published on: April 13, 2018
Polymorphonuclear leukocyte integrins in deep venous thrombosis
1Department of Internal Medicine, Cardiovascular and Renal Diseases, Università di Palermo, Palermo, Italy.
Abstract:
The polymorphonuclear leukocytes (PMN) have a role in the pathophysiology of deep venous thrombosis (DVT). We examined the phenotypical expression of PMN beta(2M)-integrins (CD ll a, CDll b, CD 11c) in a group of 19 subjects with leg DVT. PMN cells were incubated with fluorescent monoclonal antibodies against CD11a, CD11b, CD11c, and the evaluation was made by flow cytofluorimetry. The same integrins were determined after in vitro activation with 4-phorbol 12-myristate 13-acetate (PMA) and N-formyl-methionyl-leucyl-phenylalanine (fMLP). In DVT subjects, at baseline, the phenotypical expression of CD11b was decreased and that of CD11c increased when compared with normal controls. In normal subjects PMN activation with PMA and fMLP led to a constant increase of all PMN adhesion molecules, while in DVT subjects the CDl l a did not show any change. These data might have therapeutical applications, especially with the aim of preventing post-thrombotic deterioration of vein function.
Insights
Polymorphonuclear leukocytes (PMN) in deep venous thrombosis (DVT) show altered CD11b and CD11c integrin expression. DVT patients exhibit impaired PMN activation responses, suggesting therapeutic targets for preventing vein damage.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Polymorphonuclear leukocytes (PMN) play a role in deep venous thrombosis (DVT) pathophysiology.
- Beta(2)-integrins on PMNs are crucial for leukocyte adhesion and migration.
Purpose of the Study:
- To investigate the phenotypical expression of PMN beta(2)-integrins (CD11a, CD11b, CD11c) in individuals with leg DVT.
- To compare integrin expression and activation responses in DVT patients versus healthy controls.
Main Methods:
- Flow cytofluorimetry was used to analyze PMN beta(2)-integrin expression (CD11a, CD11b, CD11c) in 19 DVT subjects.
- PMN cells were evaluated at baseline and after in vitro activation with PMA and fMLP.
Main Results:
- DVT subjects showed decreased CD11b and increased CD11c expression at baseline compared to controls.
- In normal subjects, PMA and fMLP increased all PMN adhesion molecules.
- In DVT subjects, CD11a expression remained unchanged after activation, unlike in controls.
Conclusions:
- Altered PMN integrin expression and impaired activation in DVT patients may contribute to disease pathophysiology.
- These findings suggest potential therapeutic strategies targeting PMN integrins to prevent post-thrombotic vein dysfunction.
Related Concept Videos
Venous Thrombosis I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

